Neil Abdollahian

Company: Santa Ana Bio

Job title: Chief Business Officer

Bio:

Neil is the CBO of Santa Ana Bio, bringing to the role a wealth of experience spanning 25 years in corporate strategy and business development execution within the biopharmaceutical industry. Throughout his career, Neil has demonstrated a proven track record of successfully closing a diverse range of transactions, including significant in- and out-licensing agreements, strategic research collaborations, transformative mergers and acquisitions, as well as crucial private and public capital raising initiatives. Neil has held officer and executive roles at Boundless Bio, Cidara Therapeutics, Trius Therapeutics, Emerging Growth Capital, and earlier evolving roles at Avanir Pharmaceuticals, Ionis Pharmaceuticals, and Neurogen. 

Seminars:

Evaluating Bi-Specific Antibody & Cell Engager Targets, Safety & Efficacy to Uncover Their Commercial Potential 12:10 pm

Exploring emerging classes of cell engager and bispecific therapies, evaluating target populations, including macrophages, to identify applications in wider autoimmune diseases Comparing toxicity concerns for a broad population or efficacy in more targeted populations to evaluate the safety of engager and antibody applications Evaluating the safety and efficacy of bispecific antibody & cell engagers, in…Read more

day: Day Two

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.